Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 5 Results

Intervention Indication Therapeutic Area Year Actions
Benralizumab for Chronic Obstructive Pulmonary Disease (COPD) Benralizumab (Fasenra; MEDI563) Chronic obstructive pulmonary disease (COPD) Respiratory System 2017 View  |  Download
Benralizumab for treating eosinophilic oesophagitis in people aged 12-65 years Benralizumab (Fasenra; MEDI563) Eosinophilic oesophagitis Gastroenterology 2022 View  |  Download
Benralizumab for treating hypereosinophilic syndrome Benralizumab (Fasenra; MEDI563) Hypereosinophilic syndrome (HES) Immunology 2023 View  |  Download
Benralizumab for treating relapsing or refractory eosinophilic granulomatosis with polyangiitis Benralizumab (Fasenra; MEDI563) Eosinophilic granulomatosis with polyangiitis Cardiovascular System , Immunology 2022 View  |  Download
Benralizumab in addition to mometasone furoate for severe nasal polyposis Benralizumab (Fasenra; MEDI563) , Mometasone Furoate Nasal polyps Ear Nose and Throat (ENT) 2019 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications